|AC-T Regimen (Code C63427)|
|Terms & Properties|
Preferred Name: AC-T Regimen
Definition: A chemotherapy regimen consisting of doxorubucin hydrochloride (Adriamycin) and cyclophosphamide, followed by paclitaxel (Taxol), administered on either a dose-dense or sequential schedule and used as an adjuvant treatment for breast cancer.
NCI-GLOSS Definition: An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol).
Label: AC-T Regimen
NCI Metathesaurus Link: C1879500 (see NCI Metathesaurus info)
Synonyms & Abbreviations: (see Synonym Details)
External Source Codes:
|PDQ Closed Trial Search ID||631444|
|PDQ Open Trial Search ID||631444 (check for NCI PDQ open clinical trial info)|
|Name||Value (qualifiers indented underneath)|
|DesignNote||Source: NCCN Guidelines 2007|
|Semantic_Type||Therapeutic or Preventive Procedure|
Additional Concept Data:
|Defined Fully by Roles: No|